Combination of IL-24 and cisplatin inhibits cervical cancer growth in a Xenograft nude mice model

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 12, 2011, Pages 3293-3298

  Li, Li ^a   Wang, Zhao Xia ^a   Wang, Zan Hong ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Cervical carcinoma; Cisplatin; Gene therapy; IL 24; Nm23H1; Recombinant vector

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; INTERLEUKIN 24; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; MESSENGER RNA; NUCLEOSIDE DIPHOSPHATE KINASE NM23;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG SCREENING; ENZYME IMMUNOASSAY; FEMALE; GENE THERAPY; GENETICS; HUMAN; METABOLISM; MOUSE; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; FEMALE; GENE THERAPY; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84864498073     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Arbyn M, Castellsagué X, de Sanjosé S, et al (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol, doi: 10.1093/annonc/mdr015.
2. Borowsky ME, Elliott KS, Pezzullo JC, et al (2005). A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer. Bull Cancer, 92, E19-24.
3. Dash R, Bhutia SK, Azab B, et al (2010). mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine Growth Factor Rev, 21, 381-91.
4. Emdad L, Lebedeva IV, Su ZZ, et al (2009). Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. Cancer Biol Ther, 8, 391-400.
5. Freije JM, MacDonald NJ, Steeg PS (1998). Nm23 and tumour metastasis: basic and translational advances. Biochem Soc Symp, 63, 261-71.
6. Gopalkrishnan RV, Sauane M, Fisher PB (2004). Cytokine and tumor cell apoptosis inducing activity of mda-7/IL-24. Int Immunopharmacol, 4, 635-47.
7. Gupta P, Su ZZ, Lebedeva IV, et al (2006). mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol Ther, 111, 596-628.
8. Horak CE, Lee JH, Elkahloun AG, et al (2007). Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Cancer Res, 67, 7238-46.
9. Iizuka N, Hirose K, Noma T, et al (1999). The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. Br J Cancer, 81, 469-75.
10. Lee HN, Lee KH, Lee DW, et al (2011). Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer. Int J Gynecol Cancer, 21, 128-36.
11. Luo SJ, Wang XZ, Sun XB (2004). The expression and clinical significance of p16 and nm23 in the tissues of cervical carcinoma. Chin J Pract Gynecol Obstet, 20, 421-2. (in Chinese)
12. Shi H, Wei LL, Yuan CF, et al (2007). Melanoma differentiation-associated gene-7/interleukin 24 inhibits invasion and migration of human cervical cancer cells in vitro. Saudi Med J, 28, 1671-5.
13. Su Z, Emdad L, Sauane M, et al (2005). Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene, 24, 7552-66.
14. Wang PH, Ko JL, Yang SF, Lin LY (2011). Implication of human nonmetastatic clone 23 Type 1 and its downstream gene lipocalin 2 in metastasis and patient's survival of cancer of uterine cervix. Int J Cancer, 129, 2380-9.
15. Whitaker EL, Filippov V, Filippova M, et al (2011). Splice variants of mda-7/IL-24 differentially affect survival and induce apoptosis in U2OS cells. Cytokine, 56, 272-81.
16. Wu YM, Zhang KJ, Yue XT, et al (2009). Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24. Acta Pharmacol Sin, 30, 467-77.
17. Yacoub A, Liu R, Park MA, et al (2010). Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells. Mol Pharmacol, 77, 298-310.
18. Yang C, Tong Y, Ni W, et al (2010). Inhibition of autophagy induced by overexpression of mda-7/interleukin-24 strongly augments the antileukemia activity in vitro and in vivo. Cancer Gene Ther, 17, 109-19.
19. Zhang TZ, Xu GW (1996). Oncology. Tianjin Science and Technology Publishing House, Tianjin, pp 375. (in Chinese)